Skip to content
Sign in
Venture capitalBacked 1 network startup

Alpenroute Asset Management

Seoul asset manager seen in BILIX's seed (kidney-injury drug); its thesis, ticket and team are not documented.

Seoul, South Korea
Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
1most often with DS Asset Management

How they invest

Unknown from the record. The only known deal is BILIX (drug for acute kidney injury) at seed, suggesting Korean biotech exposure.

Stage and ticket

Unknown; one known seed participation.

Geography

South Korea (HQ Seoul).

What makes them say yes

  • Inferred: Korean biotech with clinical pathway
  • Inferred: syndicates with Korean VCs (DS Asset Management, KDDF)
  • Unknown: validate directly

Red flags

  • Unknown
  • Inferred: no Korea link

Sectors

Not published

Stages

Not published

Geographies

Not published

How to approach

Ask BILIX's team for context and an introduction. Validate mandate before pitching.

Portfolio

1 network startup · no other company

One network deal (BILIX seed); Korean pharma co-investor set.

Gaps in the portfolio

  • Thesis undocumented

Network startups

  • BILIXSWC 2026 Finalist

    South Korea · Biotech & life sciences

    KAIST spin-off developing PEGylated bilirubin BX-001N to prevent acute kidney injury after cardiac surgery, now in phase 2a in Korea.

Network startups that fit

3 analysed

HKUST polymer-therapeutics platform entering the clinic in dry eye, with osteoarthritis and aesthetics as follow-on indications.

Polymer-based therapeutics with a first-in-human trial authorised: clinical-stage biotech like BILIX. China-based, so Korean investor fit is unproven.

20%confidence

Evidence from the records

  • “Polymer-based therapeutics (ophthalmology, osteoarthritis, regenerativ”
  • “First-in-human trial of candidate P002 (dry eye) authorized by Health Canada”
First step
Confirm Alpenroute's cross-border biotech appetite via BILIX.

Spatial AI that automates MEP design and BIM-based AR verification for AI data centres and semiconductor fabs.

Korean spatial-AI digital twins sold to semiconductor players: a Korean seed company, but outside the known biotech pattern.

20%confidence

Evidence from the records

  • “Spatial AI / digital twins for industrial construction (MEP)”
  • “South Korea”
First step
Check whether Alpenroute invests in Korean deep-tech software.

Busan maritime engineering startup applying advanced process control and AI to ship LNG fuel systems, fire suppression and aquaculture.

Korean maritime AI/process control at Series A with installed systems: Korean industrial tech; sector fit unknown.

15%confidence

Evidence from the records

  • “AI and process control for the maritime sector”
  • “Series A”
First step
Low priority; validate mandate first.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with DS Asset Management

Sources

  1. 1thevc.kr/bilix/fundings

Profile compiled from public sources. Unknown fields are left empty rather than estimated.